Collegium Pharmaceutical, Inc.
COLL Nasdaq
SEC CIK 1267565
Follow Collegium Pharmaceutical
Weekly email: filings, results
Revenue, last quarter
$216.3M
+3.3% vs same quarter last year
Net income
$21.8M
−30.9% vs same quarter last year
EPS, diluted
$0.60
−28.6% vs same quarter last year
Operating cash flow
$86.5M
+10.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $780.6M | $63M |
| FY24 | $631.4M | $69M |
| FY23 | $566.8M | $48M |
| FY22 | $463.9M | −$25M |
| FY21 | $276.9M | $72M |
| FY20 | $310M | $26.8M |
| FY19 | $296.7M | −$22.7M |
| FY18 | $280.4M | −$39.1M |
| FY17 | $28.5M | −$74.9M |
| FY16 | $1.7M | −$94.2M |
| FY15 | - | −$27.3M |
| FY14 | - | −$17.9M |
| FY13 | - | −$16.2M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 59.3% | 23% | 8.1% |
| FY24 | 59.8% | 26.9% | 10.9% |
| FY23 | 57.5% | 29.5% | 8.5% |
| FY22 | 45.2% | 7.2% | −5.4% |
| FY21 | 54.4% | 6.4% | 26% |
| FY20 | 58% | 18.1% | 8.6% |
| FY19 | 34.7% | −8% | −7.7% |
| FY18 | 40.9% | −7.4% | −14% |
| FY17 | 90.9% | −264.9% | −262.9% |
| FY16 | 87.6% | −5498.7% | −5504.1% |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $327.6M |
| FY24 | $203.3M |
| FY23 | $274.3M |
| FY22 | $122.6M |
| FY21 | $101.6M |
| FY20 | $88.4M |
| FY19 | $21.3M |
| FY18 | $163.9M |
| FY17 | −$68M |
| FY16 | −$75.5M |
| FY15 | −$21.9M |
| FY14 | −$18M |
| FY13 | −$16.7M |
| FY12 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $25.1M |
| FY24 | $60M |
| FY23 | $75M |
| FY22 | $14.1M |
| FY21 | $47.9M |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
- Collegium Pharmaceutical
- Healthcare median
Show the numbers
| Year | Collegium Pharmaceutical | Healthcare median |
|---|---|---|
| FY25 | 8.1% | −30.6% |
| FY24 | 10.9% | −47% |
| FY23 | 8.5% | −58% |
| FY22 | −5.4% | −80.4% |
| FY21 | 26% | −71.8% |
| FY20 | 8.6% | −62.2% |
| FY19 | −7.7% | −46.2% |
| FY18 | −14% | −49.6% |
| FY17 | −262.9% | −45.9% |
| FY16 | −5504.1% | −36% |
| FY15 | - | −37.8% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |